Taniguchi M - Search Results

1

NKT cells as an ideal anti-tumor immunotherapeutic.

Fujii S, Shimizu K, Okamoto Y, Kunii N, Nakayama T, Motohashi S, Taniguchi M. Fujii S, et al. Among authors: taniguchi m. Front Immunol. 2013 Dec 2;4:409. doi: 10.3389/fimmu.2013.00409. Front Immunol. 2013. PMID: 24348476 Free PMC article. Review.

2

Tumor cells loaded with alpha-galactosylceramide induce innate NKT and NK cell-dependent resistance to tumor implantation in mice.

Shimizu K, Goto A, Fukui M, Taniguchi M, Fujii S. Shimizu K, et al. Among authors: taniguchi m. J Immunol. 2007 Mar 1;178(5):2853-61. doi: 10.4049/jimmunol.178.5.2853. J Immunol. 2007. PMID: 17312129

3

Adjuvant activity mediated by iNKT cells.

Fujii S, Motohashi S, Shimizu K, Nakayama T, Yoshiga Y, Taniguchi M. Fujii S, et al. Among authors: taniguchi m. Semin Immunol. 2010 Apr;22(2):97-102. doi: 10.1016/j.smim.2009.10.002. Epub 2009 Nov 24. Semin Immunol. 2010. PMID: 19939703 Review.

4

Preserved IFN-alpha production of circulating Valpha24 NKT cells in primary lung cancer patients.

Motohashi S, Kobayashi S, Ito T, Magara KK, Mikuni O, Kamada N, Iizasa T, Nakayama T, Fujisawa T, Taniguchi M. Motohashi S, et al. Among authors: taniguchi m. Int J Cancer. 2002 Nov 10;102(2):159-65. doi: 10.1002/ijc.10678. Int J Cancer. 2002. PMID: 12385012 Free article.

5

The regulatory role of Valpha14 NKT cells in innate and acquired immune response.

Taniguchi M, Harada M, Kojo S, Nakayama T, Wakao H. Taniguchi M, et al. Annu Rev Immunol. 2003;21:483-513. doi: 10.1146/annurev.immunol.21.120601.141057. Epub 2001 Dec 19. Annu Rev Immunol. 2003. PMID: 12543936 Review.

6

Impaired IFN-gamma production of Valpha24 NKT cells in non-remitting sarcoidosis.

Kobayashi S, Kaneko Y, Seino K, Yamada Y, Motohashi S, Koike J, Sugaya K, Kuriyama T, Asano S, Tsuda T, Wakao H, Harada M, Kojo S, Nakayama T, Taniguchi M. Kobayashi S, et al. Among authors: taniguchi m. Int Immunol. 2004 Feb;16(2):215-22. doi: 10.1093/intimm/dxh020. Int Immunol. 2004. PMID: 14734606

7

Down-regulation of the invariant Valpha14 antigen receptor in NKT cells upon activation.

Harada M, Seino K, Wakao H, Sakata S, Ishizuka Y, Ito T, Kojo S, Nakayama T, Taniguchi M. Harada M, et al. Among authors: taniguchi m. Int Immunol. 2004 Feb;16(2):241-7. doi: 10.1093/intimm/dxh023. Int Immunol. 2004. PMID: 14734609

8

Valpha14 NKT cell-mediated anti-tumor responses and their clinical application.

Seino K, Fujii S, Harada M, Motohashi S, Nakayama T, Fujisawa T, Taniguchi M. Seino K, et al. Among authors: taniguchi m. Springer Semin Immunopathol. 2005 Jun;27(1):65-74. doi: 10.1007/s00281-004-0194-y. Epub 2005 Jan 14. Springer Semin Immunopathol. 2005. PMID: 15650847 Review.

9

Induction of regulatory properties in dendritic cells by Valpha14 NKT cells.

Kojo S, Seino K, Harada M, Watarai H, Wakao H, Uchida T, Nakayama T, Taniguchi M. Kojo S, et al. Among authors: taniguchi m. J Immunol. 2005 Sep 15;175(6):3648-55. doi: 10.4049/jimmunol.175.6.3648. J Immunol. 2005. PMID: 16148109

10

Natural killer T cell-mediated antitumor immune responses and their clinical applications.

Seino K, Motohashi S, Fujisawa T, Nakayama T, Taniguchi M. Seino K, et al. Among authors: taniguchi m. Cancer Sci. 2006 Sep;97(9):807-12. doi: 10.1111/j.1349-7006.2006.00257.x. Epub 2006 Jun 29. Cancer Sci. 2006. PMID: 16805854 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

3,107 results

Search Page